000 | 00747 a2200241 4500 | ||
---|---|---|---|
005 | 20250511230015.0 | ||
264 | 0 | _c19900914 | |
008 | 199009s 0 0 eng d | ||
022 | _a0093-7754 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aByar, D P | |
245 | 0 | 0 |
_aThe importance and nature of cancer prevention trials. _h[electronic resource] |
260 |
_bSeminars in oncology _cAug 1990 |
||
300 |
_a413-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xepidemiology |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 | _aResearch Design |
700 | 1 | _aFreedman, L S | |
773 | 0 |
_tSeminars in oncology _gvol. 17 _gno. 4 _gp. 413-24 |
|
999 |
_c2207205 _d2207205 |